Related Experiment Video
Updated: Jan 15, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
VV-ECMO for TRALI/TACO During Treatment of Hemorrhagic Gastric Ulcer: A Case Report
Mayu Shindo1, Hiroshi Matsuura1, Hiroshi Hino1
1Osaka Prefectural Nakakawachi Emergency and Critical Care Center Osaka Japan.
Abstract:
A 77-year-old man with no medical history was admitted with hematemesis. Vital signs indicated shock, and massive amounts of allogeneic blood were transfused. His respiratory condition deteriorated, and veno-venous extracorporeal membrane oxygenation (VV-ECMO) was initiated. He was weaned from VV-ECMO and transferred to another hospital on Day 59.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

